PACT logo

Find a trial

PACT COVID-19 Update

Many pulmonary fibrosis trials have been suspended whilst our respiratory health professionals are called to the frontline of the COVID-19 response. Many sites are not accepting new trial enrolments. For patients already in a trial, extraordinary measures are now in place such as clinic visits being conducted over the phone or computer, medications posted and monitoring performed by GPs.
Recruiting trials listed below remain ongoing, although recruitment is temporarily suspended for many at present. Therefore, we are not currently accepting enquiries relating to these trials. Please continue to check our website for updates.

Deciding to be part of a clinical trial is a very personal decision. People eligible to participate in a clinical trial are limited to a group with very specific characteristics. Please see below clinical trials that are currently recruiting in Australasia. If you are interested in any of the listed trials please register your interest by clicking here.  You will then be able to enter your contact details which will then be forwarded to the PACT coordinator. If you are interested in participating in a trial your information may be passed onto a local clinical trials coordinator.

Recruiting Trials

Trial

Title

Status

More Information
SCENIC Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study with Inhaled RVT-1601 for the Treatment of Persistent Cough in Patients with Idiopathic Pulmonary Fibrosis (IPF): SCENIC Trial Recruiting

Trial Summary

Study ID: NCT03864328
Isabela 1&2 A Phase 3, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Two Doses of GLPG1690 in Addition to Local Standard of Care for Minimum 52 Weeks in Subjects With ldiopathic Pulmonary Fibrosis Recruiting

Trial Summary

Study ID: NCT0371l-162 Study ID NCT03733444
Trail1 A study of Pirfenidone in patients with Rheumatoid Arthritis with Interstitial Lung Disease Recruiting Trial Summary

Study Id: NCT02808871
PFOX PFOX: Pulmonary Fibrosis Ambulatory Oxygen Trial Recruiting

Trial Summary

Study ID: NCT03737409
ATLAS A Randomized Open-Label, Phase 1b Study of the Safety of Pirfenidone Solution for Inhalation (AP01) in Patients with Idiopathic Pulmonary Fibrosis Recruiting

Trial Summary

Study Id: ACTRN12618001838202
HIIT High intensity interval training in fibrotic interstitial lung disease Recruiting

Trial Summary

Study Id: NCT03800914
GRIPF Genetic research in Idiopathic Pulmonary Fibrosis (GRIPF) Recruiting

Trial Summary

Not Applicable
HHF-ILD Handheld fan for breathlessness in interstitial lung disease Recruiting

Trial Summary

Study ID: ACTRN12618001949279

Completed Trials

Trial

Title

Status

More Information
COLDICE Cryobiopsy versus Open Lung biopsy in the Diagnosis of Interstitial lung disease allianCE Study completed

Trial Summary

Study Id: ACTRN12615000718549
SPIRIT A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of BG00011 in Patients With Idiopathic Pulmonary Fibrosis (IPF) Study completed

Trial Summary

ClinicalTrials.gov

Study ID: NCT03573505